Content
05/07/2025
New York, NY USA
Inductive Bio
completed $25 million Series A Round funding. Investors include
Obvious Ventures (lead), Lux Capital, Andreessen Horowitz, S32, Character, Amino Collective.
About
Inductive Bio has developed a collaborative AI platform that dramatically accelerates compound optimization, a critical and time-consuming step in developing new therapeutics. By building a pre-competitive data consortium and state-of-the-art ML models designed to map the drivers of small molecule Absorption, Distribution, Metabolism, Excretion and Toxicity (ADMET), Inductive's platform allows scientists to optimize initial compounds into leads and development candidates faster and with a better balance of ADMET properties.
Startup
Sector:
AI
Life Science
Software
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
